Cetera Advisors LLC Medpace Holdings, Inc. Transaction History

Cetera Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$284.87 - $413.31 $459,780 - $667,082	1,614 Added 162.37%	2,608 $1.05 Million
Q4 2023 Feb 13, 2024	SELL	$227.52 - $312.68 $87,595 - $120,381	-385 Reduced 27.92%	994 $304,000
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $37,436 - $45,067	-160 Reduced 10.4%	1,379 $333,000
Q2 2023 Aug 09, 2023	BUY	$187.26 - $240.17 $24,531 - $31,462	131 Added 9.3%	1,539 $369,000
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $5,054 - $6,946	-29 Reduced 2.02%	1,408 $264,000
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $219,947 - $325,581	1,437 New	1,437 $305,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.